Related Experiment Video
Updated: Dec 13, 2025
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.9K
Tumorigenic p53 mutants undergo common structural disruptions including conversion to α-sheet structure
Dennis Bromley1, Valerie Daggett1,2
1Division of Biomedical and Health Informatics, Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.
Protein Science : a Publication of the Protein Society
|July 28, 2020
Summary
p53 protein mutations in cancer often worsen existing structural weaknesses. Targeting these common vulnerabilities, rather than individual mutations, may offer new cancer therapy strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- The p53 protein is a critical tumor suppressor, frequently mutated in approximately 50% of human cancers.
- Mutations in p53, primarily in its DNA-binding domain, lead to loss of function and contribute to cancer development.
Purpose of the Study:
- To investigate the structural dynamics of wild-type (WT) p53 and 20 mutants using molecular dynamics simulations.
- To identify common structural vulnerabilities in p53 mutants that could be targeted for therapeutic intervention.
- To explore the presence and implications of alpha-sheet secondary structures in p53 dynamics.
Main Methods:
- Utilized molecular dynamics simulations to analyze the structural behavior of wild-type p53 and 20 distinct mutants.
- Focused simulations on the central DNA-binding domain where most cancer-associated mutations occur.
- Examined the formation of secondary structures, specifically alpha-sheets, within the simulated p53 proteins.
Main Results:
- p53 mutants were found to amplify inherent structural weaknesses present in the wild-type protein.
- A common set of structural-disruption motifs was identified across various p53 mutants.
- Alpha-sheet secondary structures were observed in nearly all simulated p53 proteins, including WT and mutants.
Conclusions:
- Targeting shared structural vulnerabilities in p53 mutants, rather than individual mutations, presents a promising therapeutic avenue for cancer treatment.
- The prevalence of alpha-sheet structures in p53 simulations supports emerging theories linking cancer to amyloid diseases.
- Further research into p53 structural dynamics and alpha-sheet formation could lead to novel anti-cancer strategies.
Related Concept Videos
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
03:03Amyloid Fibrils
11.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.4K
02:04Covalently Linked Protein Regulators
8.4K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.4K
01:19Interactions Between Signaling Pathways
7.0K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
02:36DNA Damage can Stall the Cell Cycle
9.8K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.8K
02:36DNA Damage Can Stall the Cell Cycle
2.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.9K